STERIS plc (STE)
STERIS plc (STE) from its SEC filings: 2025 revenue $5.9 billion (+9% vs the year before), net margin 13%, free cash flow $972.4 million. Insider trades, recent filings and a price chart. Free.
| Exchange | NYSE |
| Industry | Orthopedic, Prosthetic & Surgical Appliances & Supplies |
| Revenue (2025) | $5.9 billion |
| Revenue growth | +9% |
| Net income | $782.3 million |
| Net margin | 13.2% |
| Free cash flow | $972.4 million |
| Diluted EPS | $7.93 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +7% |
| Cash | $482.3 million |
| Long-term debt | $1.7 billion |
| Share count, 1 year | -1% |
| Fundamentals check | Strong fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.